31 Jan 2024
AbbVie pumps $223M into Singapore biologics plant, plots 100 hires
In late 2022, GSK, Sanofi and Takeda signed on with a partnership of local agencies to advance biologic manufacturing in Singapore. Now, a little more than a year later, AbbVie is getting in on the action by starting a major production expansion in the Ga
Find out more